<--- Back to Details
First PageDocument Content
FDA Fast Track Development Program / Clinical research / Center for Biologics Evaluation and Research / Prescription Drug User Fee Act / New Drug Application / Food and Drug Administration / Pharmaceutical sciences / Medicine
FDA Fast Track Development Program
Clinical research
Center for Biologics Evaluation and Research
Prescription Drug User Fee Act
New Drug Application
Food and Drug Administration
Pharmaceutical sciences
Medicine

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 276,30 KB

Share Document on Facebook

Similar Documents

Food and Drug Administration / Medicine / Stem cells / Health care / Biology / Transplantation medicine / Good tissue practice / Allotransplantation / Blood / Center for Biologics Evaluation and Research / Cord blood / Tissue

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

DocID: 1ogsZ - View Document

Pharmaceutical industry / Food and Drug Administration / Biosimilar / Biotechnology / Drugs / Biologic / Generic drug / Center for Biologics Evaluation and Research / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Clinical research

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

DocID: 1gkCa - View Document

Pharmacology / Pharmaceutical industry / Biosimilar / Biotechnology / Drugs / Food and Drug Administration / Biologic / Center for Biologics Evaluation and Research / Generic drug / Medicine / Pharmaceutical sciences / Health

  Global  Healthy  Living  Foundation   515  North  Midland  Avenue   Upper  Nyack,  New  York  10960  USA   +1  845  348  0400  

DocID: 1g1KY - View Document

Biotechnology / Food and Drug Administration / Childbirth / Blood banks / Cord blood bank / Transplantation medicine / Cord blood / Current Good Tissue Practices / Center for Biologics Evaluation and Research / Biology / Medicine / Stem cells

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

DocID: 1fuJJ - View Document

Pharmaceutical sciences / Federal Food /  Drug /  and Cosmetic Act / Structured Product Labeling / Center for Biologics Evaluation and Research / Norfloxacin / Food and Drug Administration / Medicine / Health

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DocID: 1aZ0Q - View Document